Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Complete Summary

GUIDELINE TITLE

Wisconsin essential diabetes mellitus care guidelines.

BIBLIOGRAPHIC SOURCE(S)

  • Wisconsin Diabetes Advisory Group. Wisconsin diabetes mellitus essential care guidelines. Madison (WI): Wisconsin Diabetes Prevention and Control Program; 2008. Various p. [17 references]

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: Wisconsin Diabetes Advisory Group. Wisconsin essential diabetes mellitus care guidelines. Madison (WI): Wisconsin Diabetes Prevention and Control Program; 2004. Various p. [246 references]

COMPLETE SUMMARY CONTENT

 
SCOPE
 METHODOLOGY - including Rating Scheme and Cost Analysis
 RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 BENEFITS/HARMS OF IMPLEMENTING THE GUIDELINE RECOMMENDATIONS
 CONTRAINDICATIONS
 QUALIFYING STATEMENTS
 IMPLEMENTATION OF THE GUIDELINE
 INSTITUTE OF MEDICINE (IOM) NATIONAL HEALTHCARE QUALITY REPORT CATEGORIES
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

SCOPE

DISEASE/CONDITION(S)

  • Pre-diabetes
  • Diabetes mellitus (type 1, type 2, gestational)
  • Diabetes-related complications (diabetic foot ulceration, diabetic foot infection, Charcot foot, diabetic neuropathy, diabetic retinopathy, diabetic kidney disease, periodontal disease)

GUIDELINE CATEGORY

Counseling
Diagnosis
Evaluation
Management
Prevention
Risk Assessment
Screening
Treatment

CLINICAL SPECIALTY

Cardiology
Dentistry
Dermatology
Emergency Medicine
Endocrinology
Family Practice
Gastroenterology
Geriatrics
Infectious Diseases
Internal Medicine
Nephrology
Neurology
Nursing
Nutrition
Obstetrics and Gynecology
Ophthalmology
Optometry
Pediatrics
Pharmacology
Physical Medicine and Rehabilitation
Podiatry
Preventive Medicine
Psychiatry
Psychology
Urology

INTENDED USERS

Advanced Practice Nurses
Allied Health Personnel
Dentists
Dietitians
Emergency Medical Technicians/Paramedics
Health Care Providers
Health Plans
Hospitals
Managed Care Organizations
Nurses
Pharmacists
Physical Therapists
Physician Assistants
Physicians
Podiatrists
Psychologists/Non-physician Behavioral Health Clinicians
Public Health Departments
Social Workers
Students

GUIDELINE OBJECTIVE(S)

  • To update the 2004 Wisconsin Diabetes Mellitus Essential Care Guidelines by incorporating the latest scientific evidence regarding good diabetes care
  • To provide recommendations, which serve as a guide for the prevention and management of diabetes mellitus
  • To provide a concise, general framework for the care of diabetes and prevention of diabetes-related complications
  • To improve care and enhance quality of life for people with diabetes

TARGET POPULATION

Patients with type 1 and type 2 diabetes mellitus, pre-diabetes, and pre-gestational or gestational diabetes

INTERVENTIONS AND PRACTICES CONSIDERED

General Care

  1. Diabetes-focused visit including assessment of physical activity, diet, weight, body mass index (BMI), growth, and review of management plan
  2. Self-management education
  3. Medical nutrition therapy (MNT)
  4. Glycemic control including:
    • A1c testing
    • Review of self-monitoring of blood glucose (SMBC)
    • Review of medication management monitoring, side effects, and hypoglycemic episodes
    • Glucose-lowering agents alone or in combination with one or more oral agents and/or insulin
  5. Referral to specialists, as appropriate
  6. Essential patient education

Cardiovascular Care

  1. Lifestyle modification
  2. Tobacco cessation
  3. Lipid assessment and monitoring
  4. Statin therapy combined with lifestyle changes
  5. Blood pressure control
  6. Aspirin prophylaxis

Kidney Care

  1. Obtaining albumin/creatinine ratio, serum creatinine for estimated glomerular filtration rate (eGFR), and routine urinalysis, as appropriate
  2. Angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARB) and aggressive blood pressure therapy

Eye Care

  1. Dilated eye exams
  2. Anti-vascular endothelial growth factor (anti-VEGF) treatment
  3. Referral to ophthalmologist or optometrist and coordination of care

Neuropathies and Foot Care

  1. Classification of diabetic neuropathy
  2. Routine and comprehensive foot exams
  3. Risk categorization
  4. Management of foot ulceration and infection
  5. Management of Charcot foot

Oral Care

  1. Oral screening
  2. Dental exam
  3. Medical-dental collaboration

Emotional and Sexual Health Care

  1. Assessment of emotional health, depression screening and recommendations, including postpartum depression
  2. Assessment of sexual health concerns

Influenza and Pneumococcal Immunizations

Providing influenza and pneumococcal immunizations

Preconception and Pregnancy Care

  1. Preconception counseling
  2. Assessment of contraception/discuss family panning
  3. Screening for gestational diabetes and type 2 diabetes post-gestational diabetes mellitus
  4. Treatment of gestational diabetes
  5. Postpartum screening, breastfeeding, and lactation counseling

Identification and Diagnosis of Pre-Diabetes and Type 2 Diabetes

  1. Opportunistic and community screening
  2. Fasting plasma glucose or oral glucose tolerance test

MAJOR OUTCOMES CONSIDERED

  • Efficacy of management strategies at preventing, delaying, or reducing the risk of diabetes-related complications
  • Glycemic control
  • Quality of life
  • Cost-effectiveness of care

METHODOLOGY

METHODS USED TO COLLECT/SELECT EVIDENCE

Searches of Electronic Databases

DESCRIPTION OF METHODS USED TO COLLECT/SELECT THE EVIDENCE

Not stated

NUMBER OF SOURCE DOCUMENTS

Not stated

METHODS USED TO ASSESS THE QUALITY AND STRENGTH OF THE EVIDENCE

Not stated

RATING SCHEME FOR THE STRENGTH OF THE EVIDENCE

Not applicable

METHODS USED TO ANALYZE THE EVIDENCE

Review of Published Meta-Analyses
Systematic Review

DESCRIPTION OF THE METHODS USED TO ANALYZE THE EVIDENCE

Not stated

METHODS USED TO FORMULATE THE RECOMMENDATIONS

Expert Consensus

DESCRIPTION OF METHODS USED TO FORMULATE THE RECOMMENDATIONS

The Guidelines, originally published in 1998 and revised in 2001 and 2004, were again revised in 2008 to incorporate the latest scientific evidence regarding good diabetes care. The Wisconsin Diabetes Advisory Group and other health care professionals collaborated with the Wisconsin Diabetes Prevention and Control Program staff to update the Guidelines.

The following national and international studies were instrumental in shaping previous versions of the Guidelines and continue to shape the current Guidelines version for Wisconsin:

  • Diabetes Control and Complications Trial
  • United Kingdom Prospective Diabetes Study
  • Diabetes Prevention Program

RATING SCHEME FOR THE STRENGTH OF THE RECOMMENDATIONS

Not applicable

COST ANALYSIS

Optimal glycemic control is cost-effective and improves quality of life as well as reduces microvascular, and possible macrovascular, disease. It is estimated that for every one percent decrease in A1c, there is a 14-20% decrease in hospitalizations, resulting in $4-5 billion savings in direct health care costs alone.

METHOD OF GUIDELINE VALIDATION

Comparison with Guidelines from Other Groups
External Peer Review
Internal Peer Review

DESCRIPTION OF METHOD OF GUIDELINE VALIDATION

The authors of these Guidelines, the Wisconsin Diabetes Advisory Group, and many other individuals were involved in the review and revision of various drafts and the final document.

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

The following table presents a brief summary of the diabetes mellitus essential care guidelines. For details and references for each specific area, please refer to the full text guideline.

Concern Care/Test Frequency
General Recommendations for Care
  • Perform diabetes-focused visit
  • Review management plan; assess barriers and goals
  • Assess physical activity level
  • Assess nutrition/weight/body mass index (BMI)/growth
Type 1: Every 3 months*

Type 2: Every 3-6 months*

Each focused visit; revise as needed

Each focused visit

Each focused visit
Self-Management Education
  • Refer to diabetes educator, preferably a certified diabetes educator (CDE) in an American Diabetes Association (ADA) Recognized Program; curriculum to include the ten key areas of the national standards
At diagnosis, then every 6-12 months, or more as needed
Medical Nutrition Therapy
  • Refer for medical nutrition therapy (MNT) provided by a registered dietician (RD), preferably one who is also a certified diabetes educator
At diagnosis or first referral to RD: 3 to 4 visits, completed in 3 to 6 months; then, annually. RD determines additional visits based on needs/goals.
Glycemic Control
  • Check A1c; goal: <7.0% (always individualize)
    (ADA recognizes goal of <7.0%)
    (American Association of Clinical Endocrinologists [AACE] recognizes goal of <6.5%)
  • Review goals, medications, side effects, and frequency of hypoglycemia
  • Assess self-blood glucose monitoring schedule
Type 1: Every 3 months*

Type 2: Every 3-6 months*

Each focused visit

Each focused visit, 2-4 times/day, or as recommended
Cardiovascular Care
  • Check fasting lipid profile
Adult goals:

Total Cholesterol <200 mg/dL

Triglycerides <150 mg/dL

High-density lipoprotein (HDL) >40 mg/dL (men)

HDL >50 mg/dL (women)

Non-HDL (Cholesterol) <130 mg/dL

Low-density lipoprotein (LDL) <100 mg/dL (optimal goal)

LDL <70 mg/dL (for very high risk)
  • Start statin with ongoing lifestyle changes
  • Check blood pressure
  • Adult goal: <130/80 mmHg
  • Assess smoking/tobacco use status
  • Start aspirin prophylaxis (unless contraindicated)
Children: After age 2 but before age 10. Repeat annually if abnormal, repeat in 3‑5 years if normal.

Adults: Annually. If abnormal, follow National Cholesterol Education Program (NCEP) III guidelines.

Adults with cardiovascular disease (CVD); Age >40 yrs with one or more risk factors for CVD

Children: Each focused visit; follow National High Blood Pressure Education Program recommendations for Children and Adolescents

Adults: Each focused visit

Each visit; (5As: Ask, Advise, Assess, Assist; Arrange)

Age >40 yrs with diabetes; Age <40 yrs, individualize based on risk
Kidney Care
  • Check albumin/creatinine ratio using a random urine sample, also called urine microalbumin/creatinine ratio
  • Check serum creatinine and estimated glomerular filtration rate (GFR)
  • Perform routine urinalysis
Type 1: At puberty or after 5 years duration, then annually

Type 2: At diagnosis, then annually

At diagnosis, then annually

At diagnosis, then as indicated
Eye Care
  • Dilated eye exam by an ophthalmologist or optometrist
Type 1: If age >10, within 3-5 years of onset, then annually

Type 2: At diagnosis, then annually; two exceptions exist
Neuropathies and Foot Care
  • Assess/screen for neuropathy (autonomic/distal symmetric polyneuropathy [DPN])
  • Visual inspection of feet with shoes and socks off
  • Perform comprehensive lower extremity/foot exam (use monofilament and tuning fork)
  • Screen for peripheral vascular disease (PVD) (consider ankle-brachial index [ABI])
Type 1: Five years after diagnosis, then annually

Type 2: At diagnosis, then annually

Each focused visit; stress daily self-exam

At diagnosis, then annually

At diagnosis, then annually
Oral Care
  • Inspect gums and teeth for signs of periodontal disease
  • Dental exam by general dentist or periodontal specialist
At diagnosis, then each focused visit

At diagnosis, then every 6 months (if dentate) and every 12 months (if edentate
Emotional/Sexual Health Care
  • Assess emotional health; screen for depression
  • Assess sexual health concerns
Each focused visit

Each focused visit
Immunizations
  • Provide influenza vaccine
  • Provide pneumococcal vaccine
Annually, if age >6 months

Once; then per Advisory Committee on Immunization Practices
Preconception and Pregnancy Care
  • Provide preconception counseling/assessment
  • Assess contraception/discuss family planning
  • Assess risk for gestational diabetes mellitus (GDM)
  • Screen for GDM
  • Screen for Type 2 diabetes post-GDM
3-4 months prior to conception**

At diagnosis and each focused visit**

At first prenatal visit (if high risk, screen immediately for GDM)**

At 24-28 weeks gestation or earlier if high risk**

At 6-12 weeks postpartum, then annually
Identification and Diagnosis of Pre-diabetes and Type 2 Diabetes
  • Perform fasting plasma glucose test or oral glucose tolerance test
Test all adults >age 45 (see original guideline document for testing of Type 2 diabetes in children and adolescents); if normal and person has no risk factors, retest in 3 years or less.

*Consider more often if A1c >7.0% and/or complications exist.
**Consider referring to provider experienced in care of women with diabetes during pregnancy.

CLINICAL ALGORITHM(S)

Clinical algorithms are provided in the original guideline document for:

  • Type 2 Diabetes: Glycemic Control Pathway
  • Treatment of Hypertension
  • Screening and Initial Recommendations for Diabetic Kidney Disease (Microalbuminuria, Macroalbuminuria, and estimated glomerular filtration rate [eGFR])
  • Diabetic Foot Ulceration
  • Diabetic Foot Infection
  • Charcot Foot
  • Screening Adults for Pre-Diabetes and Type 2 Diabetes

EVIDENCE SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The recommendations are based on results of clinical trials, accepted science, and expert opinions.

BENEFITS/HARMS OF IMPLEMENTING THE GUIDELINE RECOMMENDATIONS

POTENTIAL BENEFITS

Overall Potential Benefits

  • Prevention, early detection, and aggressive treatment can have a significant impact on the quality of life for people who have diabetes.
  • The management goal for diabetes is to achieve optimal glycemic control to prevent acute and chronic complications.

Specific Potential Benefits

Self-Management Education

The primary goal of diabetes self-management education (DSME) is to provide knowledge and skill training, facilitate problem solving, help people identify barriers to change, and nurture the development of coping skills with the goal of achieving effective self-management and behavior change.

Medical Nutrition Therapy (MNT)

MNT can assist with the prevention of Type 2 diabetes, management of existing diabetes, and preventing (or at least slowing) the development of costly diabetes-related complications and hospitalizations. MNT can assist people at risk for or with diabetes to make informed and beneficial dietary changes to assist in reducing the amount of oral medication(s)/insulin needed to optimize glycemic control.

Cardiovascular Care

Aggressive assessment, prevention and treatment of cardiovascular disease through lifestyle modifications and medical interventions can lead to preventing the development of cardiovascular complications, and the prevention or reduction of occurrences or recurrences of events, enabling people with diabetes to lead healthier and longer lives.

Kidney Care

Early detection and intervention, along with improved glycemic and blood pressure control, can help reduce the risk of the development and progression of nephropathy. Screening for, and treatment of, early kidney disease resulting from diabetes adds years to life and is proven cost-effective.

Eye Care

Studies show that early detection and proper treatment reduces the risk of diabetic retinopathy and blindness by 50-60%. In addition, proper glycemic control can reduce the risk of progression of retinopathy by 34-76%. For each two unit decrease in A1c (e.g., A1c of 8.5% to 6.5%) there is a 50-75% reduction in complications. Retinal screening exams and early can result in increased years of sight and also assist with cost savings. Diabetic retinopathy is preventable; and, optimal glycemic control and blood pressure control can reduce its severity.

Neuropathies and Foot Care

Improved glycemic control and reduced variations in blood glucose excursions can slow the progression of neuropathy. Simple prevention strategies may reduce the rate of lower extremity complications in people with diabetes.

Oral Care

Individuals can avoid the negative outcomes of periodontitis through early screening, referral, and treatment.

Emotional/Sexual Health Care

Early recognition of depression symptoms, prompt treatment, and referral may lead to improved diabetes self-care and quality of life.

Influenza and Pneumococcal Immunizations

Immunizations can prevent serious illness, complications, hospitalizations, and death associated with influenza and pneumococcal disease.

Preconception and Pregnancy Care

Preconception counseling, intensive management to optimize glycemic control before pregnancy and during pregnancy, and utilizing a team of providers experienced in caring for women with diabetes can help at-risk women achieve health outcomes similar to those of women without diabetes.

Identification and Diagnosis of Pre-diabetes and Type 2 Diabetes

Without lifestyle changes, most people with pre-diabetes will develop Type 2 diabetes within ten years. Lifestyle modifications, such as dietary changes, a 5-10% weight loss, and increased physical activity (recommended 30 minutes a day, at least 5 days a week) can help return blood glucose levels to a normal range for many people.

POTENTIAL HARMS

For information on side effects of diabetes medications, see "Medication Update for Diabetes Mellitus - 2008" at the end of Section 4 in the original guideline document.

For information on side effects of lipid medications, see "Lipid Medication Update" at the end of Section 5 in the original guideline document.

For information on side effects of smoking cessation products, see "Quite Tobacco Series: Medication Chart" at the end of Section 5 in the original guideline document.

CONTRAINDICATIONS

CONTRAINDICATIONS

For information on contraindications of diabetes medications, see "Medication Update for Diabetes Mellitus - 2008" at the end of Section 4 in the original guideline document.

For information on contraindications of lipid medications, see "Lipid Medication Update" at the end of Section 5 in the original guideline document.

Angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers are contraindicated in pregnancy.

QUALIFYING STATEMENTS

QUALIFYING STATEMENTS

The Guidelines are population-based and therefore intended to be appropriate for most people with diabetes, but not intended to define the optimal level of care that an individual person may need. Clinical judgment may indicate the need for adjustments appropriate to the needs of each particular person (e.g., age, medical condition, or individual glycemic control goal).

IMPLEMENTATION OF THE GUIDELINE

DESCRIPTION OF IMPLEMENTATION STRATEGY

Quality Improvement

Quality improvement is important in assuring optimal care for people with diabetes. Implementing evidence-based guidelines such as the Wisconsin Diabetes Mellitus Essential Care Guidelines is an example of improving quality care for people with diabetes in a health system or organization. In addition, the Guidelines set a standard of care for which to measure an organization's quality improvement in care. Possible data sources to audit care in a patient population include medical records (paper or electronic), patient registries, administrative claims data, pharmacy records, lab records, or patient surveys.

IMPLEMENTATION TOOLS

INSTITUTE OF MEDICINE (IOM) NATIONAL HEALTHCARE QUALITY REPORT CATEGORIES

IOM CARE NEED

Living with Illness
Staying Healthy

IOM DOMAIN

Effectiveness
Patient-centeredness

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

  • Wisconsin Diabetes Advisory Group. Wisconsin diabetes mellitus essential care guidelines. Madison (WI): Wisconsin Diabetes Prevention and Control Program; 2008. Various p. [17 references]

ADAPTATION

Not applicable: The guideline was not adapted from another source.

DATE RELEASED

2004 Dec (revised 2008)

GUIDELINE DEVELOPER(S)

Wisconsin Diabetes Prevention and Control Program - State/Local Government Agency [U.S.]

SOURCE(S) OF FUNDING

Centers for Disease Control and Prevention (CDC), Division of Diabetes Translation

GUIDELINE COMMITTEE

Guideline Revision Workgroups
Wisconsin Diabetes Advisory Group

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Revision Workgroup Members: Sue Backes, RN, BS, AE-C, CCM, Physicians Plus Insurance Corporation; Dory Blobner, RN, MS, CDE, Diabetes Educators International; Erika Brown, CSW, Wisconsin Dental Association, Inc.; Mary Bruskewitz, RN, BC-ADM, UW Health Diabetes Clinic; Jenny Camponeschi, MS, Diabetes Prevention and Control Program, Wisconsin Department of Health Services; Pat Celek, RN, CDE, Aurora Medical Group, Wisconsin Association for Perinatal Care Preconception and Prenatal Care Committee; April Eddy, RN, CNS, CDE (APNP) Meriter Center for Perinatal Care; Diane Elson, MD,  University of Wisconsin Hospital and Clinics; Edwin Ferguson, MD, Section of Cardiovascular Medicine, University of Wisconsin School of Medicine and Public Health; Joan Fisher, RN, CCM, CDE, MercyCare Health Plans; Pamela Geis, BA, Diabetes Prevention and Control Program, Wisconsin Department of Health Services; Irene Golembiewski, MA, Media Solutions, University of Wisconsin School of Medicine and Public Health; Dee Helgeson, RN, BSN, CDE, Reedsburg Physicians Group; Thomas Haupt, MS, Communicable Disease Epidemiology Section, Wisconsin Department of Health Services; Sue Hugl, RN, BSN, CDE, Diabetes & Endocrine Center, Froedtert & Medical College of Wisconsin; Anthony M. Iacopino, DMD, PhD, University of Manitoba Faculty of Dentistry; Jonathan B. Jaffery, MD, Department of Medicine, Section of Nephrology, University of Wisconsin School of Medicine and Public Health; Audrey Johnson, RN, MSN, CDE, Aurora Health Care; Bob Johnson, MD, Wisconsin Academy of Family Physicians, Western Wisconsin Medical Associates – River Falls Medical Clinic; Virginia Jordan, MS, RD, CDE, West Central Wisconsin Area Association of Diabetes Educators; Judith Kozminski, Media Solutions, University of Wisconsin School of Medicine and Public Health; Jennifer Keeley, MS, RD, Diabetes Prevention and Control Program, Wisconsin Department of Health Services; Pamela Kittleson, RPh, UW Medical Foundation; Christy Kreul, BS, CCP, Physicians Plus Insurance Corporation; Scott Krueger, RD, CD, CDE, Wisconsin Dietetic Association and Menominee Tribal Clinic; Leah Ludlum, RN, BSN, CDE, Diabetes Prevention and Control Program, Wisconsin Department of Health Services; Steven B. Magill, MD, PhD, Midwest Endocrinology Associates and Aurora Diabetes Care Initiative, St. Luke's Medical Center; Jason Mailhot, DMD, MS, Marquette University of School of Dentistry; Melissa Meredith, MD, University of Wisconsin Hospital and Clinics; Mary Jane Mihajlovic, RN, BSN, HN-BC, CHTP, Unity Health Plans Insurance Corporation, Nutrition and Physical Activity Program, Department of Health Services; Pamela Myhre, RN, BSN, CDE, University of Wisconsin School of Nursing; Jane Nelson Worel, MS, APNP, Women's Cardiovascular Wellness Program, Meriter Heart Hospital; Angela Nimsgern, MPH, Diabetes Prevention and Control Program, Wisconsin Department of Health Services; Roxanne Radich, APNP, CNS, CDE, Fox Valley Nephrology Partners, Inc., The Diabetes Management Center; Paul M. Reber, DO, Division of Endocrinology, Dean Health Systems; Thomas Repas, DO, FACP, FACE, CDE, Regional Medical Clinic – Endocrinology, Rapid City, SD; Kathleen Rickerl, BA, RN, Mental Health Center of Dane County; Tim Ringhand, RN, MPH, Diabetes Prevention and Control Program, Wisconsin Department of Health Services; Elaine Rosenblatt, MSN, FNP-BC, UW Medical Foundation; David A. Scheidt, OD, Wisconsin Optometric Association; Thomas S. Stevens, MD, Wisconsin Academy of Ophthalmology; Alisa Sunness, RD, CDE, UW Health and Nutrition Education; Gail Underbakke, MS, RD, CD, Preventive Cardiology Program, University of Wisconsin Hospital and Clinics; Denise Walbrandt Pigarelli, PharmD, BC-ADM, University of Wisconsin School of Pharmacy, William S. Middleton VA Memorial Hospital; Naomi Wedel, MS, RD, CDE, BC-ADM, Capitol Area and Surrounding Communities Association of Diabetes Educators; William Weis, DPM, FACFAS, CWS, Wisconsin Society of Podiatric Medicine; Susan Williams, RN, CDE, Wheaton Franciscan Healthcare – St. Francis Hospital; Deborah Patrick Wubben, MD, MPH, University of Wisconsin School of Medicine and Public Health and Physicians Plus Insurance Corporation; Kara Yaeger, RN, BSN, CDE, UW Health – West Diabetes Clinic

Advisory Group Members: Della Alvarez, MS, FNP, APNP SC Johnson, Inc.; Diane Anderson, MS, RN, BC-FNP, APNP, CDE Gateway Technical College; Lori Arnoldussen, RN ThedaCare Health System; Sue Backes, RN, BS, AE-C, CCM, Physicians Plus Insurance Corporation; Jill Ballard, MPH, CHES, Evidence-Based Prevention Programs; Erika Brown, CSW Wisconsin Dental Association, Inc.; Catheryn Brue, MA, Heart Disease and Stroke Prevention Program, Wisconsin Department of Health Services; Mary Bruskewitz, RN, BC-ADM, UW Health Diabetes Clinic; Mary Carlson, WPS Health Insurance; Mariaelena Chang Calhoun, MSN, Children's Speciality Group, Medical College of Wisconsin; Isa Chase, RN, MSN, CPNP, Wisconsin Association of School Nurses; Wendy Countryman, RN, CCM, COHN-S, CVE WEA Trust; Pam Crouse, MS, RN, Wisconsin Primary Health Care Association; Diane Elson, MD, University of Wisconsin Hospital and Clinics; Elizabeth Fayram, PhD, RN, UW-Milwaukee College of Nursing; Joan Fisher, RN, CCM, CDE, MercyCare Health Plans; Charlanne FitzGerald, MPH, University of Wisconsin Population Health Institute; Susan Garman, Wisconsin Institute for Public Health; Gary Goyke, Wisconsin Council of the Blind and Visually Impaired; Sharon Gray, RN, BSN, Aurora Health Care; Yvonne D. Greer, MPH, RD, CD, Adolescent Community Health Program, City of Milwaukee Health Department; Dean Groth, MS, Pfizer, Inc., Linda Guddie, RPh, Diabetes Assessment and Resource Team, Froedtert Hospital Pharmacy; Peter Hanson, MD, Peter Christensen Health Clinic; Kristin Hill, Great Lakes Inter-Tribal Council, Inc.; Kate Holzum, RN, BSN, CDE, Diabetes Program, Children's Hospital of Wisconsin; Cindy Huber, National Kidney Foundation of Wisconsin; Todd Hughes, Novo Nordisk, Inc.; Sue Hugl, RN, BSN, CDE, Diabetes & Endocrine Center, Froedtert & Medical College of Wisconsin; Bob Johnson, MD, Wisconsin Academy of Family Physicians, Western Wisconsin Medical Associates – River Falls Medical Clinic; Virginia Jordan, MS, RD, CD, CDE, West Central Wisconsin Area Association of Diabetes Educators; Penny Kasprzak, American Diabetes Association, Wisconsin Area; Gwen Klinkner, MS, RN, ADMCNS-BC, CDE, University of Wisconsin Hospital and Clinics; Stephen R. Knapp, ProMark Communications, Inc.; Joy Kobiske, RN, MSN, FNP, CDE, Northeast Wisconsin Association of Diabetes Educators; Kevin Kortsch, DPM, Wisconsin Society of Podiatric Medicine, Inc.; Christy Kreul, BS, CCP, Physicians Plus Insurance Corporation; Scott Krueger, RD, CD, CDE, Wisconsin Dietetic Association, Menominee Tribal Clinic; Jim Lazarz, Juvenile Diabetes Research Foundation; Rob London, Independent Private Practitioner; Jason Mailhot, DMD, MS; Marquette University of School of Dentistry; W. Curtis Marshall, Southeast Regional Office, Wisconsin Division of Public Health; Suzanne Matthew, PhD, Northern Wisconsin Area Health Education Center; Patricia McManus, PhD, Black Health Coalition of Wisconsin; Melissa Meredith, MD, University of Wisconsin Hospital and Clinics; Traci Meyer, MS, Froedtert & Community Health; Mary Jane Mihajlovic, RN, BSN, HN-BC, CHTP, Unity Health Plans Insurance Corporation; Christine Miller, RN, PhD, Ruth S. Coleman College of Nursing, Cardinal Stritch University; Paula J. Miller, RN, BA, Wisconsin Lions Foundation; Gail Morgan American Heart Association, Midwest Affiliate; Timothy A. Moureau, APRN, BC-GNP, BC-ADM, CDE, Oneida Nation Community Health Center; Pam Myhre, RN, BSN, CDE, University of Wisconsin School of Nursing; Michael Nelipovich, RhD, Office for the Blind and Visually Impaired, Wisconsin Department of Health Services; Victoria O'Brien, American Heart Association, Greater Midwest Affiliate; Daniel Patterson, RN, BSN, Managed Health Services Network Health Plan; Mary Pesik, RD, CD, Nutrition and Physical Activity Program, Wisconsin Department of Health Services; John Quinette, American Diabetes Association, Wisconsin Area; Dana Richardson, MHA, RN, Wisconsin Hospital Association; Ray Ropers, Wisconsin Lions Diabetes Focus Group, Wisconsin Lions Foundation; David A. Scheidt, OD, Wisconsin Optometric Association; Joie Scheuer, BSN, RN, CDE, Southeastern Wisconsin Association of Diabetes Educators; Cynthia Schlough, Wisconsin Collaborative for Healthcare Quality; Susan Schmitz, BSN, GlaxoSmithKline; Debbie Scullin, RN, Fort Health Care; Shirley Sharp, BS, MA, Milwaukee Urban League, Inc.; Liz Shelley, Wisconsin Lions Foundation; Sonya Sidky, Wisconsin Department of Employee Trust Funds; Kay Simmons, MA, MetaStar, Inc.; Terry Spears Barnett, MD, Cream City Medical Society; Elizabeth Spencer, RD, MS, CDE, West Central Wisconsin Area Association of Diabetes Educators; Thomas S. Stevens, MD, Wisconsin Academy of Ophthalmology and Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health; Jacqueline Terry, National Black Nurses Association, Milwaukee Chapter; Julie Thiel, RPh, Pharmacy Society of Wisconsin; Melissa Tobler, RN, BSN, Wachovia Insurance Services; Anne Trinh, Great Lakes Inter-Tribal Council, Inc.; Fanaye Turner, Milwaukee Area Health Education Center; Vaughn Vance WEA Trust; Kathy Verstegen, RN, Wisconsin Association of School Nurses, Denise Walbrandt Pigarelli, PharmD, BC-ADM, Pharmacy Society of Wisconsin, University of Wisconsin School of Pharmacy; Katie Walsh, RN, CDE Innovex; Naomi Wedel, MS, RD, CDE, BC-ADM, Capitol Area and Surrounding Communities Association of Diabetes Educators; Mark Wegner, MD, MPH, Bureau of Community Health Promotion, Wisconsin Department of Health Services; Debbie Woelfel, Northeast Wisconsin Association of Diabetes Educators, Deborah Patrick Wubben, MD, MPH, University of Wisconsin School of Medicine and Public Health and Physicians Plus Insurance Corporation; Chua Xiong, Brown County Health Department; Kara Yaeger, RN, BSN, CDE, UW Health – West Diabetes Clinic; Jessica Zuercher, RN, BSN, Gerald L. Ignace Indian Health Center

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

Not stated

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: Wisconsin Diabetes Advisory Group. Wisconsin essential diabetes mellitus care guidelines. Madison (WI): Wisconsin Diabetes Prevention and Control Program; 2004. Various p. [246 references]

GUIDELINE AVAILABILITY

Electronic copies: Available from the Wisconsin Diabetes Prevention and Control Program Web site.

Print copies: Available from the Diabetes Prevention and Control Program, Wisconsin Division of Public Health, PO Box 2659, Madison, WI 53701-2659; Phone: (608) 261-6855

AVAILABILITY OF COMPANION DOCUMENTS

PATIENT RESOURCES

The following is available:

  • Diabetes self-management information and record booklet. Madison (WI): Wisconsin Diabetes Advisory Group. Department of Health and Family Services, Division of Public Health, Diabetes Prevention and Control Program. 2008. 12 p.

Electronic copies: Available in Portable Document Format (PDF) from the Wisconsin Diabetes Prevention and Control Program Web site.

Print copies: Available from the Diabetes Prevention and Control Program, Wisconsin Division of Public Health, PO Box 2659, Madison, WI 53701-2659.

Please note: This patient information is intended to provide health professionals with information to share with their patients to help them better understand their health and their diagnosed disorders. By providing access to this patient information, it is not the intention of NGC to provide specific medical advice for particular patients. Rather we urge patients and their representatives to review this material and then to consult with a licensed health professional for evaluation of treatment options suitable for them as well as for diagnosis and answers to their personal medical questions. This patient information has been derived and prepared from a guideline for health care professionals included on NGC by the authors or publishers of that original guideline. The patient information is not reviewed by NGC to establish whether or not it accurately reflects the original guideline's content.

NGC STATUS

This NGC summary was completed by ECRI on July 22, 2005. This NGC summary was updated by ECRI Institute on February 16, 2009. The updated information was verified by the guideline developer on April 7, 2009.

COPYRIGHT STATEMENT

This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions.

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo